Super-globuling for in vivo extended lifetimes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5612034
SERIAL NO

08237346

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

First and second compounds are provided, where the first compound is administered to a mammalian host into blood for covalent bonding to blood components, where the components have an extended lifetime in the blood stream. The first compound comprises an active functionality and an agent of interest or a first binding entity. A second compound may be subsequently administered to the patient, which comprises a second binding entity, complementary to the first binding entity and an agent of interest. By virtue of binding to long-lived blood components, the half-life of the agent of interest is greatly extended in vivo.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CONJUCHEM LLC10182 CULVER BOULEVARD CULVER CITY CA 90232

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Pouletty, Christine Atherton, CA 4 127
Pouletty, Philippe Atherton, CA 58 641

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation